UNSPSC 85893533: High dose rate (hdr) brachytherapy of abdomen using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of abdomen using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DW139BZ

UNSPSC 85893533 High dose rate (HDR) brachytherapy of abdomen using palladium 103 (Pd-103) is a Commodity code that shows a significant mismatch between its nominal scope and the recent state and local procurement activity recorded under it. The code describes a specialized cancer treatment modality — internal radiation therapy using radioactive palladium seeds — but the single recent opportunity posted under this code is for temporary health professional staffing services across multiple ancillary clinical categories, with no reference to brachytherapy, oncology, or radiation therapy. The Santa Clara County Health System solicitation (RFSQHHSFY270052, due October 7, 2026) establishes a qualified vendor pool for temporary placement in audiology, cardiology, diagnostic imaging, gastroenterology, respiratory care, surgical/operating room, therapy services, and other non-nursing clinical roles, bearing no operational relevance to the code's stated commodity.

The code shows little relevant recent activity. State and local procurement offices appear to have tagged the Santa Clara Health System staffing solicitation under this code in error, as the temporary staffing vehicle addresses general ancillary clinical labor across a hospital system rather than the specialized brachytherapy procedure named in the code. Business development professionals evaluating this code should verify whether the UNSPSC taxonomy is being applied correctly in their target jurisdictions' procurement systems, as the single recent opportunity offers no signal for firms positioned to deliver HDR brachytherapy services or related oncology-treatment capabilities.